Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8703)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 21, 2015 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fagiuoli S, Ravasio R, Lucà MG, Baldan A, Pecere S, Vitale A, Pasulo L. Management of hepatitis C infection before and after liver transplantation. World J Gastroenterol 2015; 21(15): 4447-4456 [PMID: 25914454 DOI: 10.3748/wjg.v21.i15.4447] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i15/4447.htm |
| Number | Citing Articles |
| 1 |
M. Buti, J. L. Calleja, S. Lens, M. Diago, E. Ortega, J. Crespo, R. Planas, M. Romero‐Gómez, F. G. Rodríguez, J. M. Pascasio, B. Fevery, D. Kurland, C. Corbett, R. Kalmeijer, W. Jessner. Simeprevir in combination with sofosbuvir in treatment‐naïve and ‐experienced patients with hepatitis C virus genotype 4 infection: a Phase III, open‐label, single‐arm study (PLUTO). Alimentary Pharmacology & Therapeutics 2017; 45(3): 468 doi: 10.1111/apt.13883
|
| 2 |
Alice Tung Wan Song, Luiz Augusto Carneiro D’Albuquerque. Emerging Transplant Infections. 2020; : 1 doi: 10.1007/978-3-030-01751-4_41-1
|
| 3 |
Alice Tung Wan Song, Luiz Augusto Carneiro D’Albuquerque. Emerging Transplant Infections. 2021; : 1011 doi: 10.1007/978-3-030-25869-6_41
|
| 4 |
Giuliano Ramadori, Patrizia Bosio, Federico Moriconi, Ihtzaz A. Malik. Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4175-2
|
| 5 |
Claudia Westermann, Madeleine Dulon, Dana Wendeler, Albert Nienhaus. Hepatitis C among healthcare personnel: secondary data analyses of costs and trends for hepatitis C infections with occupational causes. Journal of Occupational Medicine and Toxicology 2016; 11(1) doi: 10.1186/s12995-016-0142-5
|
| 6 |
Natalia Salinas Parra, Maarouf A. Hoteit, Puru Rattan, Peter Abt, Nadim Mahmud. Trends in candidate hepatitis C virus nucleic acid amplification test (NAT)+ listing and associated impacts on liver transplantation waitlist outcomes. American Journal of Transplantation 2024; doi: 10.1016/j.ajt.2024.10.016
|
| 7 |
Neal Patel, Kian Bichoupan, Lawrence Ku, Rachana Yalamanchili, Alyson Harty, Donald Gardenier, Michel Ng, David Motamed, Viktoriya Khaitova, Nancy Bach, Charissa Chang, Priya Grewal, Meena Bansal, Ritu Agarwal, Lawrence Liu, Gene Im, Jennifer Leong, Leona Kim-Schluger, Joseph Odin, Jawad Ahmad, Scott Friedman, Douglas Dieterich, Thomas Schiano, Ponni Perumalswami, Andrea Branch. Hepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus. World Journal of Gastroenterology 2016; 22(9): 2844-2854 doi: 10.3748/wjg.v22.i9.2844
|
| 8 |
Chrysoula Pipili, Evangelos Cholongitas. Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?. World Journal of Hepatology 2015; 7(12): 1606-1616 doi: 10.4254/wjh.v7.i12.1606
|
| 9 |
Kelly H. Schlendorf, Sandip Zalawadiya, Ashish S. Shah, Mark Wigger, Chan Y. Chung, Sarah Smith, Matthew Danter, Chun W. Choi, Mary E. Keebler, D. Marshall Brinkley, Suzanne Brown Sacks, Henry Ooi, Roman Perri, Joseph A. Awad, Samuel Lewis, Rachel Hayes, Heather O’Dell, Callie Darragh, Alicia Carver, Cori Edmonds, Shelley Ruzevich-Scholl, JoAnn Lindenfeld. Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. The Journal of Heart and Lung Transplantation 2018; 37(6): 763 doi: 10.1016/j.healun.2018.01.1293
|
| 10 |
Mariana Mihăilă, Cristina Mădălina Pascu, Andreea Andrunache, Cătălin Ștefan Ghenea. Antiviral Strategies in the Treatment of Human and Animal Viral Infections. Infectious Diseases 2023; 27 doi: 10.5772/intechopen.112502
|
| 11 |
Felice Nava, Alberto Chiesa, Giovanni Strepparola, Giuseppe Pennisi, Rossano Vitali, Lucia Trevisi, Alfio Lucchini. The earlier the better. The cost of health services in treating PWIDs with chronic hepatitis C: Results from a non-interventional study. MISSION 2020; (54) doi: 10.3280/mis54-2020oa10583
|
| 12 |
Ramakrishna Behara, Nancy Reau. Updates on hepatitis C virus therapy in the direct-acting antiviral era. Current Opinion in Gastroenterology 2017; 33(3): 115 doi: 10.1097/MOG.0000000000000350
|
| 13 |
Christian Rupp, Theresa Hippchen, Manuel Neuberger, Peter Sauer, Jan Pfeiffenberger, Wolfgang Stremmel, Daniel Nils Gotthardt, Arianeb Mehrabi, Karl-Heinz Weiss. Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus. World Journal of Gastroenterology 2018; 24(12): 1353-1360 doi: 10.3748/wjg.v24.i12.1353
|
| 14 |
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in Iran. Hepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
|
| 15 |
Nobuyuki Toshikuni. Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis. Gut and Liver 2017; 11(3): 335 doi: 10.5009/gnl15458
|